BackgroundThe"CPG2-prodrug"therapy is limited by toxicity:the leak of active drugs into circulation leads to severe adverse events.Therefore,the activity of CPG2 should be under control to modulate the release of active drugs.However,no such a strategy is available.ObjectiveTo determine whether ultrasound can be used to modulate the activity of CPG2.MethodsCPG2 was subjected to insonation.The activity was determined,and then Km,Vmaxax and reversibility were explored.Monomer was analyzed with SDS-PAGE,PR-HPLC and MS,and dimer was assayed with SEC-HPLC.The secondary structure was analyzed with CD,and the conformational transformationwasdeterminedwithsynchronousfluorescence spectroscopy.The ultrasonic mechanisms were explored from the perspective of heat and cavitation.Results1.Under 10 W/cm2,the activity was improved when the insonation time was?400 s,with a peak value at L1?200 s?;insonation decreased the activity when the insonation time was?700 s.The activity was decreased under 20 W/cm2 exposure;the decrease followed zero-order kinetics when the insonation time was?1000s,and displayed first-order kinetics when the insonation time was?1200 s.2.An increase or a slight decrease of activity attributable to 10 W/cm2was reversible,but the activity decrease due to 20 W/cm2 was irreversible.3.L1 improved the CPG2 activity via increasing the specific activity.L2 or L3?20 W/cm2 for 1200 or 3000 s?decreased the CPG2 activity via disassembling the dimer,degrading the monomer,inducing glycosylation,transforming conformation and decreasing the specific activity.4.Insonation induced a higher yield of free radicals in sonicated solution,but without temperature rise.Conclusion:UltrasoundcanbiphasicallymodulatetheCPG2activity.Ultrasonically enzymatic modulation was mediated by cavitation. |